GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
German medical packaging firm Gerresheimer to sell two units to Apax for $1.71 billion - Finance news and analysis from Global Banking & Finance Review
Finance

German medical packaging firm Gerresheimer to sell two units to Apax for $1.71 billion

Published by Global Banking & Finance Review

Posted on July 29, 2026

2 min read

· Last updated: July 29, 2026

Add as preferred source on Google

German medical packaging firm Gerresheimer to sell two units to Apax for $1.71 billion

Gerresheimer's Strategic Sale of Packaging Units

Overview of the Transaction

July 29 (Reuters) - German drug packaging firm Gerresheimer said on Wednesday it was selling two plastic packaging units, including the U.S business Centor, to private equity group Apax Funds for €1.5 billion ($1.71 billion) including debt.

Background and Reasons for the Sale

Accounting Investigations and Financial Impact

The sale follows internal investigations into Gerresheimer's accounting practices, which delayed its financial results and led to its removal from Deutsche Boerse's SDAX small-cap index earlier this year. Germany's financial regulator, BaFin, also opened audits of the company's financial statements.

Business Performance of the Units

The two packaging units generated combined revenue of approximately €570 million last year and employ around 2,400 people, Gerresheimer said.

Details of the Sale

Scope of the Transaction

The company started the Centor sale process in February as it sought to improve its capital structure. The sale also includes the global Primary Packaging Plastics unit, Gerresheimer said on Wednesday.

Use of Proceeds

"Gerresheimer will use the expected cash inflows to significantly optimise its capital and financing structure by meaningfully decreasing its leverage," the company said in a statement.

Assets and Sites Involved

As part of the deal, Apax will acquire Gerresheimer's 15 production sites for primary plastic packaging in nine countries and Centor's U.S. production site.

Other Strategic Decisions

Rejection of Takeover Bid

The drug packaging firm rejected a takeover bid from U.S. rival Silgan in April, choosing to focus on resolving its accounting problems and selling its U.S. subsidiary Centor, Reuters had reported.

Progress on Accounting Review

Gerresheimer said last month that its internal accounting review was complete, though its assessment of possible damages claims was still ongoing.

Timeline and Financial Details

Expected Closing Dates

The sale of Centor is expected to close by the end of financial year 2026 and the global Primary Packaging Plastics business sale in the first half of 2027.

Currency Exchange Rate

($1 = 0.8776 euros)

Reporting Credits

(Reporting by Anusha Shah in Bengaluru; Editing by Mrigank Dhaniwala and Subhranshu Sahu)

Key Takeaways

  • The sale involves two units: Centor (U.S. operations) and the Primary Packaging Plastics unit, under Apax Funds for €1.5 billion (~$1.71 billion) including debt (exchange rate €1 = $1.14).
  • Gerresheimer initiated the sale to optimize capital and financing amid an ongoing accounting investigation and delayed 2025 financial results publication.
  • The divestment aligns with its broader transformation strategy to focus on pharma and biotech packaging solutions; it follows earlier strategic moves like separating the Moulded Glass business.

Frequently Asked Questions

What units is Gerresheimer selling to Apax?
Gerresheimer is selling its U.S. packaging business Centor and its global Primary Packaging Plastics unit to Apax Funds.
What is the value of the Gerresheimer and Apax deal?
The deal is valued at €1.5 billion ($1.71 billion), including debt.
Who is acquiring Gerresheimer’s packaging units?
Private equity group Apax Funds is acquiring Gerresheimer’s Centor and Primary Packaging Plastics units.
Where is Gerresheimer based?
Gerresheimer is a German drugs packaging firm based in Düsseldorf, Germany.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category